tiprankstipranks
Trending News
More News >
Indaptus Therapeutics, Inc. (INDP)
:INDP
US Market

Indaptus Therapeutics (INDP) Income Statement

Compare
494 Followers

Indaptus Therapeutics Income Statement

Last quarter (Q4 2024), Indaptus Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Indaptus Therapeutics's net income was $-4.13M. See Indaptus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00----
Operating Expenses
$ 15.37M$ 16.38M$ 14.91M$ 7.73M$ 3.60M
Depreciation and Amortization
$ 0.00----
EBITDA
$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
Operating Income
$ -15.37M$ -16.38M$ -14.91M$ -7.73M$ -3.60M
Other Income/Expenses
$ 343.72K$ 955.00K$ 588.11K$ 17.72K$ 15.11K
Pretax Income
$ -15.02M$ -15.42M$ -14.32M$ -7.71M$ -3.58M
Net Income
$ -15.02M$ -15.42M$ -13.73M$ -7.69M$ -3.57M
Per Share Metrics
Basic EPS
$ -1.61$ -1.84$ -1.66$ -1.88$ -7.34
Diluted EPS
$ -1.61$ -1.84$ -1.66$ -1.88$ -7.34
Weighted Average Shares Outstanding
9.36M 8.40M 8.26M 4.09M 486.17K
Weighted Average Shares Outstanding (Diluted)
9.36M 8.40M 8.26M 4.09M 486.17K
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis